Anastrozole (Arimidex)

DRUG4 trials

Sponsors

Stanford University, AstraZeneca, University of Pittsburgh, University of British Columbia

Conditions

Breast CancerCerebral Blood FlowCerebral Blood Flow RegulationExerciseNon-small Cell Lung CancerPostmenopausal WomenSex DifferencesVascular

Phase 2

Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women

CompletedNCT00186121

Stanford UniversityBreast Cancer

Start: 2000-10-31End: 2013-06-30Updated: 2019-10-07

Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer

TerminatedNCT00932152

University of PittsburghNon-small Cell Lung Cancer, Postmenopausal Women

Start: 2010-09-30End: 2013-01-31Updated: 2017-10-19

Phase 3

ATAC - Endometrial Sub-Protocol

CompletedNCT00814125

AstraZenecaBreast Cancer

Start: 1997-06-30End: 2005-12-31Updated: 2009-05-01

Unknown Phase

The Role of Estrogen and Testosterone in Determining Brain Blood Flow and Metabolic Regulation in Humans

Not yet recruitingNCT07212712

University of British ColumbiaCerebral Blood Flow, Cerebral Blood Flow Regulation, Exercise +2

Start: 2026-04-01End: 2027-12-31Target: 50Updated: 2026-02-10